FBLG insider trading
NasdaqCM HealthcareFibroBiologics, Inc.: insider trade history from SEC Form 4 filings.
About FibroBiologics, Inc.
FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.
Company website: fibrobiologics.com
FBLG insider activity at a glance
FilingIQ tracks 13 insider transactions for FBLG in filings since Aug 12, 2024. The most recent transaction is dated Sep 15, 2026.
Across the full history, 10 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on FBLG insider trades is 62.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest FBLG Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for FBLG?
- FilingIQ tracks 13 Form 4 insider transactions for FBLG (FibroBiologics, Inc.), covering filings from Aug 12, 2024 onwards. 1 of those are dated within the last 90 days.
- Are FBLG insiders net buyers or net sellers?
- Across the full Form 4 history for FBLG, 10 transactions (77%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does FBLG insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is FBLG in?
- FibroBiologics, Inc. (FBLG) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $22.47M.
Methodology & sources
Every FBLG insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.